Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Deal Watch: Best Value For Smaller Firms Lies In The Back-End

DealWatch_1200x675

Related Content

AstraZeneca, Eli Lilly and Cancer Dominate 2016 EU New Drug Approvals

Jan 12 2017

SDP Completes Tolero Buy To Build Oncology Ahead Of Key Expiry

Jan 26 2017

Can Actelion Founder Clozel Recreate Another Top Biotech Post-J&J Sale?

Jan 26 2017

Billions On The Line With Celgene’s Partnered Pipeline

Jan 27 2017

J&J’s $30bn For Actelion Buys Immediate And Longer-Term Value

Jan 26 2017

Piramal Stays The M&A Course; Snaps Up Niche Mallinckrodt Assets

Jan 30 2017

Incyte Further Enhances IO Pipeline With Calithera's Arginase Inhibitor

Jan 30 2017

Takeda Adds Exelixis Arrow To Oncology Quiver

Jan 31 2017

Related Companies

Incyte Corporation

Calithera Biosciences, Inc.

Bristol Myers Squibb Company

Delinia, Inc.

Anokion SA

Merck KGaA

Domain Therapeutics S.A.

MOD3 Pharma

Ferring Pharmaceuticals

Astellas Pharma, Inc.

Stanford University

Alteogen Inc.

Qilu Pharmaceutical Co., Ltd.

Cristalia Produtos Quimicos Farmaceuticos Ltda.

Takeda Pharmaceutical Co. Ltd.

Exelixis, Inc.

Incyte Corporation

Calithera Biosciences, Inc.

Piramal Enterprises Limited

Mallinckrodt plc

Johnson & Johnson

Actelion Pharmaceuticals Ltd.

Sumitomo Pharma Co., Ltd.

Additional Topics

Deals M & A Business Strategies Commercial BioPharmaceutical

More from Deals

More from Business

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window